FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
399 letters match. Newest first.
-
DrugsMedical Mega
FDA: Medical Mega sells unapproved triclosan antiseptic soaps as nonprescription drugs.
Medium -
DrugsSeema International
FDA warns Seema International over unclean API equipment, missing stability data, and quality-unit failures after inspection; APIs adulterated.
High risk -
DrugsSinsin Pharmaceutical Co., Ltd.
FDA warned Sinsin Pharmaceutical that two Korean topical pain relievers sold in the US are unapproved and misbranded drugs.
High risk -
DrugsUriel Pharmacy, Inc.
Uriel Pharmacy's homeopathic ampule drugs are unapproved new drugs and were made under serious CGMP violations.
High risk -
DrugsKorea Filler Experts
FDA warned Korea Filler Experts that its website sells unapproved and misbranded injectable botulinum toxin drugs, including Nabota 100UI, to U.S. consumers.
High risk -
DrugsIBSPOT.com Inc.
FDA says IBSPOT.com sold unapproved motion sickness patches containing diphenhydramine and diclofenac that the labels never listed.
High risk -
DrugsCosmenic
FDA warned Panama-based Cosmenic that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsDermacare dba Filler Outlet
South Korea's Dermacare, doing business as Filler Outlet, sells unapproved, misbranded injectable botulinum toxin to U.S. consumers through its website.
High risk -
DrugsMaypharm
Maypharm website sells unapproved, misbranded Botulax botulinum toxin to U.S. consumers, FDA says.
High risk -
DrugsEstaderma
FDA warned South Korea's Estaderma that its website sells unapproved, misbranded injectable botulinum toxin (Liztox) to U.S. consumers.
High risk -
DrugsKorean Aesthetic dba Korean Fillers
FDA warned Korean Fillers that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsCelestaPro
FDA told CelestaPro its website sells unapproved, misbranded injectable botulinum toxin drugs, including "Nabota 200 Unit", to U.S. consumers.
High risk -
DrugsAceCosm
AceCosm’s website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
DrugsDermax Co., Ltd
FDA warned China's Dermax Co., Ltd. over its website selling unapproved, misbranded injectable botulinum toxin to U.S. consumers.
High risk -
DrugsGlow Nest Beauty
FDA warned Glow Nest Beauty that its website sells unapproved, misbranded injectable botulinum toxin Rentox 200U.
High risk -
DrugsAesthetic Essentials Limited
Hong Kong company Aesthetic Essentials Limited sells not-FDA-approved, mislabeled injectable botulinum toxin drugs online to U.S. consumers.
High risk -
DrugsElle Pharm
FDA warned Elle Pharm that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsCOSMO KOREA
FDA told South Korea's COSMO KOREA that its website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers.
High risk -
DrugsGlam Derma
FDA warns Glam Derma over website selling unapproved, misbranded injectable botulinum toxin products.
High risk -
DrugsMeamo
Meamo's website sells unapproved, misbranded injectable botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
DrugsMJS Medicals
FDA warned South Korea's MJS Medicals for selling unapproved, misbranded botulinum toxin ("Innotox") to U.S. consumers online.
High risk -
DrugsDerma Solution
FDA warned Derma Solution for selling unapproved, misbranded injectable Botulax botulinum toxin drugs online to U.S. consumers.
High risk -
DrugsGlowface
Glowface's website sells unapproved, misbranded injectable Botulax botulinum toxin drugs to U.S. consumers, FDA says.
High risk -
Drugsonlineotcmeds.com
FDA warned onlineotcmeds.com for selling unapproved, misbranded opioids, benzodiazepines, and Schedule II stimulants to U.S. consumers online.
High risk -
DrugsMelcare Biomedical Pty Ltd
Australia's Melcare Biomedical sells Optimel Manuka+ eye gel and drops in the US as unapproved drugs with honey as an active ingredient.
High risk -
Drugswww.usmedschoice.com
FDA warned www.usmedschoice.com for selling unapproved and misbranded opioids, benzodiazepines, and stimulants online without prescriptions.
High risk -
DevicesLEVO AG
FDA says LEVO AG lacked a quality system, adverse-event reporting procedures, and device ID data for standup wheelchairs.
High risk -
DrugsHealth and Natural Beauty USA Corp.
FDA warns Health and Natural Beauty USA over CGMP failures and unapproved, misbranded SprinJene OTC toothpastes, including children’s products.
High risk -
DevicesTechnological Medical Advancements LLC
Technological Medical Advancements LLC marketed Diowave laser systems for unapproved uses without required FDA clearance and had serious quality-system failures.
High risk -
BiologicsNew Life Medical Services, LLC
FDA says New Life Medical Services sells unapproved umbilical-cord, amniotic-fluid, and exosome products as drugs.
High risk -
DrugsDixon Investments Inc. dba ARI
FDA cites Dixon Investments (ARI) for manufacturing-rule and unapproved/misbranded OTC aerosol drug violations.
High risk -
FoodGracie's Kitchens, Inc.
FDA warns Gracie's Kitchens over Listeria on RTE produce food-contact surfaces and sanitation failures.
High risk -
FoodTan Nam Corporation
FDA warned Tan Nam Corporation that its ready-to-eat soybean products were held under insanitary conditions and may be contaminated.
High risk -
FoodHans Bakery Inc. d/b/a Andersen’s Bakery
FDA found rodent and insect filth and serious food-safety failures at Hans Bakery's Hayward, CA facility making ready-to-eat bakery items and tuna salad.
High risk -
FoodValentine Enterprises, Inc.
FDA warned Valentine Enterprises that its dietary supplements were adulterated by manufacturing violations and misbranded by label errors.
Medium -
FoodVidaslim Co.
Vidaslim Co. dietary supplements are adulterated by CGMP failures and misbranded by label violations.
Medium -
FoodSTNR Creations, LLC
STNR Creations sells Delta-8 THC foods that FDA says are adulterated because Delta-8 THC is an unsafe food additive.
High risk -
DrugsStellalife, Inc.
FDA told Stellalife its homeopathic oral care gels and rinses are unapproved new drugs sold without FDA approval.
High risk -
Drugsmotionpharmacy.com
FDA warns motionpharmacy.com over selling unapproved and misbranded prescription drugs online.
High risk -
DrugsPureRawz
FDA warns PureRawz its tianeptine products are unapproved new drugs sold with drug claims.
High risk -
DevicesThe Richline Group, Inc.
FDA warns Richline Group over unapproved Inverness ear care products and quality-system failures.
High risk -
Drugscheaptrustedpharmacy.com
cheaptrustedpharmacy.com sells unapproved, misbranded prescription drugs to U.S. consumers online, FDA warns.
High risk -
DrugsExpert Aesthetics
FDA warned Expert Aesthetics over website claims that its compounded semaglutide and tirzepatide are generic Ozempic and Mounjaro.
Low -
DrugsHealthy Living Clinic
FDA warned Healthy Living Clinic that its website misbrands compounded semaglutide by comparing it to Wegovy, Ozempic, and Rybelsus.
Low -
DrugsAmazing Meds
FDA warned online seller Amazing Meds over unapproved compounded retatrutide and a misleading "same as Ozempic/Wegovy" semaglutide claim.
High risk -
DrugsGenLabMeds
GenLabMeds offered compounded retatrutide, semaglutide and tirzepatide online as unapproved, misbranded drugs with false or misleading claims.
High risk -
DrugsiVisitDoc, Inc. dba iVisitDoc
FDA warns iVisitDoc over website claims that compounded semaglutide is equivalent to Wegovy and Ozempic, calling the drugs misbranded.
Medium -
DrugsLovely Meds, Inc. dba Lovely Meds
FDA cited Lovely Meds for misleading website claims that compounded semaglutide and tirzepatide are the same as FDA-approved drugs.
Low -
DrugsVitals RX
FDA warned telehealth seller Vitals RX that its website falsely implies compounded semaglutide and tirzepatide are the approved drug Ozempic.
Medium -
DrugsAytu Biopharma
FDA says Aytu Biopharma’s sponsored links for ADHD drug Cotempla XR-ODT are false or misleading and misbrand it.
High risk